Welcome to LookChem.com Sign In|Join Free

CAS

  • or

6319-45-5

Post Buying Request

6319-45-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

6319-45-5 Usage

Description

N1-Methyl-4-nitrobenzene-1-sulfonamide, also known as 4-Nitrobenzene-1-sulfonamide, is a nitrogen and sulfur organic compound with a molecular structure that includes a benzene sulfonamide unit, an additional nitro group, and a methyl group. It is commonly found as a white solid powder at room temperature and is used in the production of various drugs and pharmaceuticals within the field of organic chemistry.

Uses

Used in Pharmaceutical Industry:
N1-Methyl-4-nitrobenzene-1-sulfonamide is used as a chemical intermediate for the synthesis of various drugs and pharmaceuticals. Its unique molecular structure allows it to be a key component in the development of new medications, contributing to the advancement of healthcare and treatment options.
Used in Organic Chemistry Research:
In the field of organic chemistry, N1-Methyl-4-nitrobenzene-1-sulfonamide serves as a valuable compound for research purposes. It is utilized in the study of chemical reactions and mechanisms, providing insights into the behavior of nitrogen and sulfur organic compounds and their potential applications in various chemical processes.

Check Digit Verification of cas no

The CAS Registry Mumber 6319-45-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,3,1 and 9 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 6319-45:
(6*6)+(5*3)+(4*1)+(3*9)+(2*4)+(1*5)=95
95 % 10 = 5
So 6319-45-5 is a valid CAS Registry Number.
InChI:InChI=1/C7H8N2O4S/c1-8-14(12,13)7-4-2-6(3-5-7)9(10)11/h2-5,8H,1H3

6319-45-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name N-Methyl-4-nitrobenzenesulfonamide

1.2 Other means of identification

Product number -
Other names N-methyl-4-nitrobenzenesulfonamide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:6319-45-5 SDS

6319-45-5Relevant articles and documents

N-Methylation of Amines with Methanol in the Presence of Carbonate Salt Catalyzed by a Metal-Ligand Bifunctional Ruthenium Catalyst [(p-cymene)Ru(2,2′-bpyO)(H2O)]

Liu, Peng,Tung, Nguyen Thanh,Xu, Xiangchao,Yang, Jiazhi,Li, Feng

, p. 2621 - 2631 (2021/02/27)

A ruthenium complex [(p-cymene)Ru(2,2′-bpyO)(H2O)] was found to be a general and efficient catalyst for the N-methylation of amines with methanol in the presence of carbonate salt. Moreover, a series of sensitive substituents, such as nitro, ester, cyano, and vinyl groups, were tolerated under present conditions. It was confirmed that OH units in the ligand are crucial for the catalytic activity. Notably, this research exhibited the potential of metal-ligand bifunctional ruthenium catalysts for the hydrogen autotransfer process.

Controlled anchoring of (Phenylureido)sulfonamide-based receptor moieties: An impact of binding site multiplication on complexation properties

?t’astná, Lucie ?ervenková,Cu?ínová, Petra,Eigner, Václav,Krupková, Alena,Müllerová, Monika,Salvadori, Karolína,Stra?ák, Tomá?

, (2021/09/28)

The repetition of urea-based binding units within the receptor structure does not only lead to monomer properties multiplication. As confirmed by spectroscopic studies, UV-Vis and1H-NMR in classical or competitive titration mode, the attachment

MACROCYCLIC COMPOUNDS FOR THE TREATMENT OF MEDICAL DISORDERS

-

Page/Page column 453; 545; 546, (2020/03/29)

Compounds, methods of use, and processes for making inhibitors of complement factor D or a pharmaceutically acceptable salt or composition thereof are provided. The inhibitors described herein target factor D and inhibit or regulate the complement cascade. The inhibitors of factor D described herein reduce excessive activation of complement.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 6319-45-5